Farther Finance Advisors’s Oruka Therapeutics ORKA Stock Holding History

Farther Finance Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.33K	Buy	40 +19	+90%	+$1.79K	﹤0.01%	5199
2026 Q2	$1.99K	Buy	21 +9	+75%	+$600	﹤0.01%	5169
2026 Q1	$605	Buy	12 +2	+20%	+$70	﹤0.01%	5226
2025 Q4	$303	Hold	10	–	–	﹤0.01%	5137
2025 Q3	$192	Buy	+10	New	+$148	﹤0.01%	4726

Other funds holding ORKA

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's ORKA Position: Q3 2026 in Review

Farther Finance Advisors increased its Oruka Therapeutics (ORKA) stake by 90% in Q3 2026, buying an estimated $1.79K and bringing the position to 40 shares worth $3.33K. The position accounts for ﹤0.01% of the portfolio, ranked #5199.

Farther Finance Advisors first reported a position in ORKA in Q3 2025 and has held it in 5 quarters since. 4 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

Farther Finance Advisors held 40 shares of Oruka Therapeutics worth $3.33K as of Q3 2026.
Farther Finance Advisors bought 19 Oruka Therapeutics shares in Q3 2026, an estimated $1.79K.
Oruka Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5199 holding.
Farther Finance Advisors first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 5 quarters since.
4 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.